News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Premier Biomedical To Present Positive Pre-Clinical Breast Cancer Study At American Association for Cancer Research Annual Meeting


2/26/2014 12:17:12 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

EL PASO, TX--(Marketwired - Feb 26, 2014) - Premier Biomedical, Inc. (OTCQB: BIEI), a biopharmaceutical company focused on developing and commercializing innovative immune-system manipulation therapies for breast cancer, as well as potential novel therapies for Alzheimer's disease and traumatic brain injury, announced today that Premier Biomedical will present significantly positive results from duplicated testing on mice at the American Association for Cancer Research annual meeting in San Diego, California on April 5-9, 2014. The results demonstrated statistically significant improvements in survival and a prevention of breast cancer in mice treated with Premier Biomedical's anti-breast cancer treatment compared to both chemotherapy and a non-treated control group.

Help employers find you! Check out all the jobs and post your resume.

Read at Market Wired

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES